Showing results (301-310 of 322) with videos related to

Sort By:
Pageof 33
Transplantation Proceedings|February 7, 2018
Slow Progression of Aortic Calcification Is a Potential Benefit of Pre-emptive Kidney TransplantationH Mursawa, S Hatakeyama, H Yamamoto, et al.
Environmental Science & Technology|January 6, 2021
Amphiphilic Thiol Polymer Nanogel Removes Environmentally Relevant Mercury Species from Both Produced Water and HydrocarbonsYilin Zhang, Garret D Bland, Jiajun Yan, et al.
Transplantation Proceedings|March 25, 2014
BK virus-associated urothelial carcinoma of a ureter graft in a renal transplant recipient: a case reportM Oikawa, S Hatakeyama, T Fujita, et al.
Transplantation Proceedings|October 15, 2018
Condyloma Acuminata of the Urethra in a Male Renal Transplant Recipient: A Case ReportI Hamano, S Hatakeyama, H Yamamoto, et al.
Transplantation Proceedings|March 25, 2014
Renal cell carcinoma detected by preoperative kidney transplant donor examination: a case reportT Sato, Takahiro Yoneyama, K Hagiwara, et al.
Transplantation Proceedings|March 25, 2014
Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experienceS Hatakeyama, T Fujita, R Murakami, et al.
ESMO Real World Data and Digital Oncology|July 13, 2026
Subsequent systemic therapy initiation after first-line discontinuation in metastatic renal cell carcinoma: insights from a Japanese real-world cohortH Sato, T Narita, Y Sekine, et al.
Immunobiology|April 25, 2000
Delayed clearance of zymosan-induced granuloma and depressed phagocytosis of macrophages with concomitant up-regulated kinase activities of Src-family in a human monocyte chemoattractant protein-1 transgenic mouseM Ato, K Iwabuchi, N Matsuki, et al.
ESMO Real World Data and Digital Oncology|July 13, 2026
Real-world safety and efficacy of enzalutamide versus darolutamide in nonmetastatic castration-resistant prostate cancer: a multicenter retrospective studyK Ishimoto, N Fujita, S Kato, et al.
ESMO Real World Data and Digital Oncology|August 8, 2026
JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in JapanH Kitamura, T Kobayashi, Y Endo, et al.
Pageof 33